thiazolidines has been researched along with Precursor T-Cell Lymphoblastic Leukemia-Lymphoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, HC; Chen, Y; Liao, H; Lin, Z; Liu, M; Liu, Y; Sun, H; Zhang, X | 1 |
| Bellon, M; Lu, L; Nicot, C | 1 |
2 other study(ies) available for thiazolidines and Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
| Article | Year |
|---|---|
Treatment of human T-cell acute lymphoblastic leukemia cells with CFTR inhibitor CFTRinh-172.
Topics: Apoptosis; Benzoates; Cell Cycle; Cell Proliferation; Cystic Fibrosis Transmembrane Conductance Regulator; Gene Expression Regulation; Humans; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Signal Transduction; Thiazolidines; Transcriptome; Tumor Cells, Cultured | 2019 |
Constitutive activation of Pim1 kinase is a therapeutic target for adult T-cell leukemia.
Topics: Animals; Apoptosis; Biphenyl Compounds; Cell Adhesion; Cell Line, Transformed; Enzyme Activation; Gene Expression Regulation, Leukemic; Gene Silencing; HEK293 Cells; Human T-lymphotropic virus 1; Humans; Mice; MicroRNAs; Molecular Targeted Therapy; Mutation; Neoplasm Proteins; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-pim-1; Signal Transduction; STAT3 Transcription Factor; Thiazolidines; Xenograft Model Antitumor Assays | 2016 |